Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04862650Phase 2Active Not Recruiting
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
PrincipalinvestigatorStart date: 2021-11-30

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Siwen Hu-Lieskovan

SWOG Cancer Research Network

Related
2 trials

Shared therapeutic areas:

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+6 more
Similarity Score11%

Loren K Mell

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Unknown PrimaryStage IVA Hypopharyngeal Carcinoma AJCC v8Stage IVA Laryngeal Cancer AJCC v8+4 more
Similarity Score8%

Eileen H Shinn

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IV Hypopharyngeal Carcinoma AJCC v8Stage IV Laryngeal Cancer AJCC v8Stage IVA Hypopharyngeal Carcinoma AJCC v8+3 more
Similarity Score7%

George Blumenschein, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+3 more
Similarity Score7%

Nabil F. Saba, MD

Emory University

Related
2 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more
Similarity Score6%

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma
Similarity Score4%

Kathryn M. Van Abel, MD

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma
Similarity Score4%

Roxana S. Dronca, M.D.

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score2%

Mojun Zhu, M.D.

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score2%

Hassan Arshad

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04862650Phase 2PrincipalInvestigator

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
Active Not Recruiting

All 1 trials loaded